FDA approves updated Covid vaccines from Pfizer and Moderna as hospitalizations rise
Publishing timestamp: 2023-09-11 16:08:08
Summary
The FDA has approved updated Covid vaccines from Pfizer and Moderna targeting the omicron variant XBB.1.5. The vaccines are expected to be available to the public soon pending recommendations from the CDC. Novavax's vaccine is still under review. The arrival of the updated vaccines offers reassurance as Covid cases and hospitalizations increase. The vaccine rollout will be the first since the end of the U.S. Covid public health emergency, and distribution will shift to the private market. The Biden administration will urge Americans to receive the updated Covid shot, but it is unclear how many will actually get vaccinated.
Sentiment: NEUTRAL
Keywords: coronavirus, health care industry, social issues, business news, breaking news, novavax inc, biotech and pharmaceuticals, moderna inc, fda, centers for disease control and prevention, business, covid-19 vaccine rollout, pandemics, united states, pharmaceuticals, pfizer inc, immunizations, biotechnology, covid-19,
Source: https://www.cnbc.com/2023/09/11/covid-vaccines-fda-approves-new-shots-from-pfizer-moderna.html